Althea’s eXpress Pathway program is a proven and highly efficient route to developing novel gene expression based molecular diagnostics.  Althea develops diagnostics under a collaboration model with diagnostic companies, reference laboratories, academia and drug development companies.  To each collaboration Althea brings its extensive laboratory resources, data analysis capabilities, QA/QC oversight, and experience in GLP clinical analysis and GMP manufacturing to create rigorous gene expression assays that are used in retrospective and prospective trials designed with the partner.